These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development]. Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013 [TBL] [Abstract][Full Text] [Related]
3. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus]. Fischer K Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227 [TBL] [Abstract][Full Text] [Related]
4. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus. Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261 [TBL] [Abstract][Full Text] [Related]
5. Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding. Belizna CC; Richard V; Primard E; Kerleau JM; Cailleux N; Louvel JP; Marie I; Hamidou M; Thuillez C; Lévesque H Semin Arthritis Rheum; 2008 Jun; 37(6):373-80. PubMed ID: 17977581 [TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I Lupus; 2006; 15(2):80-6. PubMed ID: 16539278 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Avcin T; Silverman ED Lupus; 2007; 16(8):627-33. PubMed ID: 17711899 [TBL] [Abstract][Full Text] [Related]
8. Flow-mediated arterial dilation in primary antiphospholipid syndrome. Bilora F; Sartori MT; Zanon E; Campagnolo E; Arzenton M; Rossato A Angiology; 2009; 60(1):104-7. PubMed ID: 18388060 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070 [TBL] [Abstract][Full Text] [Related]
10. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response. Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371 [TBL] [Abstract][Full Text] [Related]
11. Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study. Di Minno MND; Emmi G; Ambrosino P; Scalera A; Tufano A; Cafaro G; Peluso R; Bettiol A; Di Scala G; Silvestri E; Prisco D Int J Cardiol; 2019 Jan; 274():1-6. PubMed ID: 30454720 [TBL] [Abstract][Full Text] [Related]
12. Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus. Wirestam L; Saleh M; Svensson C; Compagno M; Zachrisson H; Wetterö J; Sjöwall C Lupus; 2021 Jul; 30(8):1244-1253. PubMed ID: 33957796 [TBL] [Abstract][Full Text] [Related]
15. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418 [TBL] [Abstract][Full Text] [Related]
16. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Falaschi F; Ravelli A; Martignoni A; Migliavacca D; Sartori M; Pistorio A; Perani G; Martini A Arthritis Rheum; 2000 Jun; 43(6):1405-9. PubMed ID: 10857801 [TBL] [Abstract][Full Text] [Related]
17. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. Charakida M; Besler C; Batuca JR; Sangle S; Marques S; Sousa M; Wang G; Tousoulis D; Delgado Alves J; Loukogeorgakis SP; Mackworth-Young C; D'Cruz D; Luscher T; Landmesser U; Deanfield JE JAMA; 2009 Sep; 302(11):1210-7. PubMed ID: 19755700 [TBL] [Abstract][Full Text] [Related]
18. Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Colombo BM; Murdaca G; Caiti M; Rodriguez G; Grassia L; Rossi E; Indiveri F; Puppo F Ann N Y Acad Sci; 2007 Jun; 1108():121-6. PubMed ID: 17893978 [TBL] [Abstract][Full Text] [Related]
19. Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Cacciapaglia F; Zardi EM; Coppolino G; Buzzulini F; Margiotta D; Arcarese L; Vadacca M; Amoroso A; Afeltra A Lupus; 2009 Mar; 18(3):249-56. PubMed ID: 19213864 [TBL] [Abstract][Full Text] [Related]
20. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]